By most measures, deal activity in the US health services industry declined in Q3 when compared quarter-over-quarter and year-over-year. However, total M&A deal value increased by 23.8% in comparison to Q2 2016. Deal value growth was largely led by the Hospitals and Labs, MRI & Dialysis sub-sectors.
There were five transactions in Q3 2016 exceeding $1.0 billion, two more than Q2 2016, with 51% higher deal value. Megadeals represented approximately 75% of total deal value for the quarter.